{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T18:25:52Z","timestamp":1783189552393,"version":"3.54.6"},"reference-count":35,"publisher":"The Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,2,1]]},"DOI":"10.1210\/jc.2017-01899","type":"journal-article","created":{"date-parts":[[2017,12,7]],"date-time":"2017-12-07T19:08:29Z","timestamp":1512673709000},"page":"523-531","source":"Crossref","is-referenced-by-count":26,"title":["New Neoplasm During GH Replacement in Adults With Pituitary Deficiency Following Malignancy: A KIMS Analysis"],"prefix":"10.1210","volume":"103","author":[{"given":"Katarzyna","family":"Krzyzanowska-Mittermayer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders F","family":"Mattsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Maiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulla","family":"Feldt-Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Camacho-H\u00fcbner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Luger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Abs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2017,12,7]]},"reference":[{"issue":"2","key":"key\n\t\t\t\t20180205135701_B1","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/cncr.23169","article-title":"Trends in childhood cancer incidence in the U.S. (1992-2004)","volume":"112","author":"Linabery","year":"2008","journal-title":"Cancer"},{"key":"key\n\t\t\t\t20180205135701_B2","doi-asserted-by":"crossref","first-page":"103032","DOI":"10.1155\/2012\/103032","article-title":"Risk of late mortality and second malignant neoplasms among 5-year survivors of young adult cancer: a report of the Childhood, Adolescent, and Young Adult Cancer Survivors Research Program","volume":"2012","author":"Zhang","year":"2012","journal-title":"J Cancer Epidemiol"},{"issue":"22","key":"key\n\t\t\t\t20180205135701_B3","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1001\/jama.2013.6296","article-title":"Clinical ascertainment of health outcomes among adults treated for childhood cancer","volume":"309","author":"Hudson","year":"2013","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180205135701_B4","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1046\/j.1365-2265.1999.00695.x","article-title":"The effects of treatment in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety.","volume":"50","author":"Abs","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8710","key":"key\n\t\t\t\t20180205135701_B5","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0140-6736(90)91812-O","article-title":"Premature mortality due to cardiovascular disease in hypopituitarism","volume":"336","author":"Ros\u00e9n","year":"1990","journal-title":"Lancet"},{"issue":"11","key":"key\n\t\t\t\t20180205135701_B6","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1210\/jcem.84.11.6088","article-title":"The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults","volume":"84","author":"Bengtsson","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"key\n\t\t\t\t20180205135701_B7","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/EJE-12-1088","article-title":"Long-term effects of recombinant human GH replacement in adults with GH deficiency: a systematic review","volume":"169","author":"Appelman-Dijkstra","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t20180205135701_B8","unstructured":"The European Medicines Agency\n          . Committee for Proprietary Medicinal Products (CPMP) opinion following an Article 7(5) Referral. Genotropin. 26 June 2003. Available at: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Referrals_document\/Genotropin_7_5\/WC500013685.pdf. Accessed 6 December 2017."},{"key":"key\n\t\t\t\t20180205135701_B9","unstructured":"The Food and Drug Administration. Label for Genotropin. Revised September 2014. Available at: http:\/\/www.fdaguidance.net\/wp-content\/uploads\/2014\/10\/Drug-Safety-Labeling-Changes.pdf. Accessed 6 December 2017."},{"key":"key\n\t\t\t\t20180205135701_B10","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1530\/eje.0.148S009","article-title":"Long-term experience with GH replacement therapy: efficacy and safety","volume":"148","author":"Monson","year":"2003","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"key\n\t\t\t\t20180205135701_B11","first-page":"2","article-title":"Hypopituitary control and complications study (HypoCCS): a decade of an outcomes assessment observational study","volume":"31","author":"Lamberts","year":"2008","journal-title":"J Endocrinol Invest"},{"issue":"9","key":"key\n\t\t\t\t20180205135701_B12","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1210\/jc.2010-0287","article-title":"Serum insulin-like growth factor I (IGF-I), IGF-binding proteins 2 and 3, and the risk for development of malignancies in adults with growth hormone (GH) deficiency treated with GH: data from KIMS (Pfizer International Metabolic Database)","volume":"95","author":"Popovic","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"key\n\t\t\t\t20180205135701_B13","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1530\/EJE-11-0286","article-title":"Assessment of primary cancers in GH-treated adult hypopituitary patients: an analysis from the Hypopituitary Control and Complications Study","volume":"165","author":"Child","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"key\n\t\t\t\t20180205135701_B14","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1530\/EJE-11-1028","article-title":"Overall and cause-specific mortality in GH-deficient adults on GH replacement","volume":"166","author":"Gaillard","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"key\n\t\t\t\t20180205135701_B15","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1530\/EJE-14-1123","article-title":"Incidence of primary cancers and intracranial tumour recurrences in GH-treated and untreated adult hypopituitary patients: analyses from the Hypopituitary Control and Complications Study","volume":"172","author":"Child","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"key\n\t\t\t\t20180205135701_B16","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1530\/EJE-07-0164","article-title":"Influence of GH substitution therapy in deficient adults on the recurrence rate of hormonally inactive pituitary adenomas: a case control study","volume":"157","author":"Buchfelder","year":"2007","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"key\n\t\t\t\t20180205135701_B17","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1530\/EJE-09-0572","article-title":"Comparing progression of non-functioning pituitary adenomas in hypopituitarism patients with and without long-term GH replacement therapy","volume":"161","author":"Olsson","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"key\n\t\t\t\t20180205135701_B18","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(13)70107-4","article-title":"Constine L, Woodman C, Bhatia S, Keller K, Bashore L. Subsequent neoplasms of the CNS among survivors of childhood cancer. a systematic review","volume":"14","author":"Bowers","year":"2013","journal-title":"Lancet Oncol"},{"issue":"7","key":"key\n\t\t\t\t20180205135701_B19","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1210\/jcem.87.7.8606","article-title":"Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study","volume":"87","author":"Sklar","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"key\n\t\t\t\t20180205135701_B20","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1210\/jc.2006-0656","article-title":"Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor","volume":"91","author":"Ergun-Longmire","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"key\n\t\t\t\t20180205135701_B21","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1530\/EJE-12-0967","article-title":"Incidence of second neoplasm in childhood cancer survivors treated with GH: an analysis of GeNeSIS and HypoCCS","volume":"168","author":"Woodmansee","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"key\n\t\t\t\t20180205135701_B22","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1210\/jc.2013-4159","article-title":"Growth hormone exposure as a risk factor for the development of subsequent neoplasms of the central nervous system: a report from the childhood cancer survivor study","volume":"99","author":"Patterson","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"key\n\t\t\t\t20180205135701_B23","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s10072-015-2269-z","article-title":"Growth hormone therapy and risk of recurrence\/progression in intracranial tumors: a meta-analysis","volume":"36","author":"Shen","year":"2015","journal-title":"Neurol Sci"},{"key":"key\n\t\t\t\t20180205135701_B24","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1210\/jc.2015-1002","article-title":"Risk of neoplasia in pediatric patients receiving growth hormone therapy\u2014a report from the Pediatric Endocrine Society Drug and Therapeutics Committee","volume":"100","author":"Raman","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180205135701_B25","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1530\/EJE-08-0293","article-title":"Retesting the childhood-onset GH-deficient patient","volume":"159","author":"Gasco","year":"2008","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"key\n\t\t\t\t20180205135701_B26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/1740028032000131396","article-title":"Thirty years of bioethics: the Helsinki Declaration 1964-2003","volume":"1","author":"Riis","year":"2003","journal-title":"New Rev Bioeth"},{"key":"key\n\t\t\t\t20180205135701_B27","volume-title":"Cancer Incidence in Five Continents Vol. IX","author":"Curado"},{"key":"key\n\t\t\t\t20180205135701_B28","doi-asserted-by":"crossref","first-page":"89S","DOI":"10.1016\/S0021-9681(87)80012-7","article-title":"Nonparametric estimation of relative mortality functions","volume":"40","author":"Breslow","year":"1987","journal-title":"J Chronic Dis"},{"issue":"4","key":"key\n\t\t\t\t20180205135701_B29","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/mpo.1316","article-title":"Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project","volume":"38","author":"Robison","year":"2002","journal-title":"Med Pediatr Oncol"},{"issue":"5","key":"key\n\t\t\t\t20180205135701_B30","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1210\/jc.2016-2046","article-title":"Cancer risks in patients treated with growth hormone in childhood: the SAGhE European Cohort Study","volume":"102","author":"Swerdlow","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"16","key":"key\n\t\t\t\t20180205135701_B31","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/jnci\/djs298","article-title":"Radiation-related risk of basal cell carcinoma: a report from the Childhood Cancer Survivor Study","volume":"104","author":"Watt","year":"2012","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"key\n\t\t\t\t20180205135701_B32","doi-asserted-by":"crossref","first-page":"666","DOI":"10.3171\/jns.1994.81.5.0666","article-title":"Meningiomas: genetics, malignancy, and the role of radiation in induction and treatment. The Richard C. Schneider Lecture","volume":"81","author":"Wilson","year":"1994","journal-title":"J Neurosurg"},{"issue":"4","key":"key\n\t\t\t\t20180205135701_B33","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3390\/genes2041033","article-title":"Modeling the risk of secondary malignancies after radiotherapy","volume":"2","author":"Schneider","year":"2011","journal-title":"Genes (Basel)"},{"issue":"1","key":"key\n\t\t\t\t20180205135701_B34","first-page":"27","article-title":"Malignant astrocytoma following radiation for nasopharyngeal carcinoma: case report and review of the literature","volume":"16","author":"Lin","year":"2007","journal-title":"Acta Neurol Taiwan"},{"issue":"2","key":"key\n\t\t\t\t20180205135701_B35","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0360-3016(90)90107-U","article-title":"CNS tumor induction by radiotherapy: a report of four new cases and estimate of dose required","volume":"18","author":"Cavin","year":"1990","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/103\/2\/523\/23792319\/jc.2017-01899.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,2,5]],"date-time":"2018-02-05T18:58:55Z","timestamp":1517857135000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/103\/2\/523\/4705941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,7]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,12,7]]},"published-print":{"date-parts":[[2018,2,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2017-01899","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,2]]},"published":{"date-parts":[[2017,12,7]]}}}